Case number 2:23-cv-03371
ACTELION PHARMACEUTICALS LTD et al v. MSN LABORATORIES PRIVATE LIMITED et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 14, 2023 | 8 | CONSENT JUDGMENT that all claims, counterclaims, affirmative defenses and demands in this action are dismissed with prejudice and without costs, disbursements or attorneys' fees to any party. Signed by Judge Stanley R. Chesler on 11/14/2023. (sm) (Entered: 11/14/2023) (4) |
| Nov 10, 2023 | 7 | Letter from Keith J. Miller, Esq. to Hon. Stanley R. Chesler, U.S.D.J. re Proposed Consent Judgment. (Attachments: # 1 Text of Proposed Order)(MILLER, KEITH) (Entered: 11/10/2023) (0) |
| Sep 8, 2023 | 5 | WAIVER OF SERVICE Returned Executed by ACTELION PHARMACEUTICALS LTD, ACTELION PHARMACEUTICALS US, INC.. MSN PHARMACEUTICALS INC. waiver sent on 9/6/2023, answer due 12/5/2023. (MILLER, KEITH) (Entered: 09/08/2023) (1) |
| Sep 8, 2023 | 6 | WAIVER OF SERVICE Returned Executed by ACTELION PHARMACEUTICALS LTD, ACTELION PHARMACEUTICALS US, INC.. MSN LABORATORIES PRIVATE LIMITED waiver sent on 9/6/2023, answer due 12/5/2023. (MILLER, KEITH) (Entered: 09/08/2023) (1) |
| Jun 21, 2023 | N/A | Judge Stanley R. Chesler and Magistrate Judge Edward S. Kiel added. (ps) (Entered: 06/21/2023) (0) |
| Jun 21, 2023 | 3 | AO120 Patent Form filed. (sm) (Entered: 06/21/2023) (1) |
| Jun 21, 2023 | 4 | SUMMONS ISSUED as to MSN LABORATORIES PRIVATE LIMITED, MSN PHARMACEUTICALS INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (sm) (Entered: 06/21/2023) (2) |
| Jun 20, 2023 | 1 | COMPLAINT against MSN LABORATORIES PRIVATE LIMITED, MSN PHARMACEUTICALS INC. ( Filing and Admin fee $ 402 receipt number ANJDC-14400788) , Related Case Selected, filed by ACTELION PHARMACEUTICALS LTD, ACTELION PHARMACEUTICALS US, INC.. (Attachments: # 1 Exhibit 1 to Complaint, # 2 Civil Cover Sheet)(MILLER, KEITH) (Entered: 06/20/2023) (0) |
| Jun 20, 2023 | 2 | Corporate Disclosure Statement by ACTELION PHARMACEUTICALS LTD, ACTELION PHARMACEUTICALS US, INC. identifying Johnson & Johnson as Corporate Parent.. (MILLER, KEITH) (Entered: 06/20/2023) (2) |
| Jun 20, 2023 | 1 | Complaint* (1) |
